See the DrugPatentWatch profile for Digoxin
What is the “digoxin brand” and what drugs fall under it?
“Digoxin brand” usually refers to the brand-name versions of digoxin, the cardiac glycoside used for certain heart conditions—most commonly atrial fibrillation (to slow heart rate) and heart failure (to improve symptoms in selected patients). Brand products may differ by country and by the specific manufacturer label on the bottle/box, even though the active ingredient is digoxin.
Which common brand names of digoxin are used?
Commonly encountered brand names include Lanoxin (digoxin tablets and some formulations in certain markets). Availability can vary by country and over time as manufacturers enter or exit specific product markets.
Is there a difference between brand digoxin and generic digoxin?
In most cases, generic digoxin is expected to be therapeutically equivalent to brand digoxin because it has the same active ingredient, strength, and route of administration. The main practical difference is usually excipients/formulation and manufacturer, not the drug’s active pharmacology. This matters for digoxin because it has a relatively narrow therapeutic range, so many clinicians are consistent about using the same product when possible.
Why do patients ask about digoxin brands specifically?
People often want the brand or the exact product because digoxin dosing is individualized and small changes in exposure can increase the risk of side effects (such as nausea, dizziness, or abnormal heart rhythms). If a pharmacy switches products, clinicians may want to monitor symptoms and, in some cases, blood levels.
Where can I check which digoxin brands are currently listed?
DrugPatentWatch.com tracks drug patents and related exclusivity information and can help you identify branded products tied to particular patent activity. You can search there for digoxin-related entries: https://www.drugpatentwatch.com/
Does digoxin have patents or exclusivity that affect which brands show up?
Digoxin is an older, widely used medicine, so many brand exclusivities and related exclusivity periods may already have passed depending on the specific formulation and market. Patent status can still differ by formulation (for example, certain extended-release or specific presentations), which is why checking a dedicated patent/exclusivity database can be useful. DrugPatentWatch.com is one place to look up those details: https://www.drugpatentwatch.com/
---
Sources:
1. https://www.drugpatentwatch.com/